Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q7251543> ?p ?o }
Showing triples 1 to 37 of
37
with 100 triples per page.
- Q7251543 subject Q8760194.
- Q7251543 subject Q8794458.
- Q7251543 abstract "Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.It is developing PRT-201, a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). On September 10, 2008, Proteon announced that the Food and Drug Administration had granted fast track status to PRT-201.Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include MPM Capital, Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks, Vectis Life Sciences and Intersouth Partners. They have invested over $72 million in the company.On March 5, 2009, the company announced that it had raised $32 million from its existing investors plus MPM Capital and Vectis Life Sciences. Proteon also announced that it had entered into an option agreement to be acquired by Novartis for up to $550 million.".
- Q7251543 industry Q12140.
- Q7251543 type Q1589009.
- Q7251543 wikiPageExternalLink daily30.html.
- Q7251543 wikiPageExternalLink newscolumn2-Proteon-chief-pulls-the-GelTex-band-back-together.html.
- Q7251543 wikiPageExternalLink www.proteontherapeutics.com.
- Q7251543 wikiPageExternalLink www.proteontherapeutics.com.
- Q7251543 wikiPageWikiLink Q12140.
- Q7251543 wikiPageWikiLink Q1581.
- Q7251543 wikiPageWikiLink Q1589009.
- Q7251543 wikiPageWikiLink Q17109789.
- Q7251543 wikiPageWikiLink Q17141450.
- Q7251543 wikiPageWikiLink Q193727.
- Q7251543 wikiPageWikiLink Q41819.
- Q7251543 wikiPageWikiLink Q49190.
- Q7251543 wikiPageWikiLink Q507154.
- Q7251543 wikiPageWikiLink Q771.
- Q7251543 wikiPageWikiLink Q8760194.
- Q7251543 wikiPageWikiLink Q8794458.
- Q7251543 homepage www.proteontherapeutics.com.
- Q7251543 industry Q12140.
- Q7251543 name "Proteon Therapeutics".
- Q7251543 type Q1589009.
- Q7251543 type Organization.
- Q7251543 type Agent.
- Q7251543 type Company.
- Q7251543 type Organisation.
- Q7251543 type Agent.
- Q7251543 type SocialPerson.
- Q7251543 type Thing.
- Q7251543 type Q43229.
- Q7251543 comment "Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.It is developing PRT-201, a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). On September 10, 2008, Proteon announced that the Food and Drug Administration had granted fast track status to PRT-201.Proteon was founded by Dr. F.".
- Q7251543 label "Proteon Therapeutics".
- Q7251543 homepage www.proteontherapeutics.com.
- Q7251543 name "Proteon Therapeutics".